Evidence map›Paper›PMID 25155147›Full record

ReviewWiley interdisciplinary reviews. RNA

The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Jonathan M Howard, Jeremy R Sanford

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. RNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Alternative splicing and cancer: a systematic review.Signal transduction and targeted therapy · 2021
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. RNA Splicing as a Therapeutic Target in Cancer.Annual review of pharmacology and toxicology · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. SRSF9-Mediated Exon Recognition Promotes Exon 2 Inclusion inInternational journal of molecular sciences · 2025
    Article
  19. Article
  20. Targeting RNA splicing modulation: new perspectives for anticancer strategy?Journal of experimental & clinical cancer research : CR · 2025
    Review

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan M HowardDepartment of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA, USA.
Jeremy R Sanford

Funding

Regulation of mRNA isoform fateR01GM109146 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SANFORD, JEREMY ROBERT · 2014 to 2017
$1.2M
Controlling toxic RNA with rapamycinR21AG042003 · NIA · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SANFORD, JEREMY ROBERT · 2013 to 2014
$420k
NIA NIH HHS AG042003NIA NIH HHS R21 AG042003NIGMS NIH HHS R01 GM109146
6 · The paper itself

Abstract

Serine and arginine-rich (SR) proteins play multiple roles in the eukaryotic gene expression pathway. Initially described as constitutive and alternative splicing factors, now it is clear that SR proteins are key determinants of exon identity and function as molecular adaptors, linking the pre-messenger RNA (pre-mRNA) to the splicing machinery. In addition, now SR proteins are implicated in many aspects of mRNA and noncoding RNA (ncRNA) processing well beyond splicing. These unexpected roles, including RNA transcription, export, translation, and decay, may prove to be the rule rather than the exception. To simply define, this family of RNA-binding proteins as splicing factors belies the broader roles of SR proteins in post-transcriptional gene expression.

Indexed as

Gene Expression RegulationRNA Processing, Post-TranscriptionalActive Transport, Cell NucleusNuclear ProteinsProtein BiosynthesisRNA-Binding ProteinsRNA PrecursorsRNA StabilitySerine-Arginine Splicing FactorsTranscription, GeneticNuclear ProteinsRNA-Binding ProteinsRNA PrecursorsSerine-Arginine Splicing Factors

Identifiers

PMID25155147
PMCPMC4268343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.